Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.
暂无分享,去创建一个
P. Ueland | R. Berge | S. Frøland | F. Müller | A. Svardal | P. Aukrust | B. Lunden | F. Müller | P. Aukrust | Fredrik Müller | RK Berge
[1] G. Schieven,et al. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. , 1994, Journal of immunology.
[2] K. Schulze-Osthoff,et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] J. Ameisen. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. , 1994, AIDS.
[4] D. Bredesen,et al. INVITED COMMENTARY IS APOPTOSIS MEDIATED BY REACTIVE OXYGEN SPECIES , 1994 .
[5] Glen,et al. Changes in plasma amino acid concentrations in response to HIV-1 infection. , 1994, Clinical chemistry.
[6] Staal,et al. Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Meister. Glutathione-ascorbic acid antioxidant system in animals. , 1994, The Journal of biological chemistry.
[8] J. V. D. van der Meer,et al. Monochlorobimane does not selectively label glutathione in peripheral blood mononuclear cells. , 1994, Analytical biochemistry.
[9] N. Liabakk,et al. Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .
[10] S. Jenkinson,et al. Induction of intracellular glutathione in alveolar type II pneumocytes following BCNU exposure. , 1994, The American journal of physiology.
[11] T. Buttke,et al. Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. , 1994, The Journal of biological chemistry.
[12] T. Buttke,et al. Oxidative stress as a mediator of apoptosis. , 1994, Immunology today.
[13] A. Yamauchi,et al. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. , 1993, Journal of immunology.
[14] D. Rabier,et al. Intra- and interlaboratory quality control for assay of amino acids in biological fluids: 14 years of the French experience. , 1993, Clinical chemistry.
[15] F. Piétri-Rouxel,et al. Thiol reagents increase the affinity of the inositol 1,4,5-trisphosphate receptor. , 1993, The Journal of biological chemistry.
[16] K. A. Balasubramanian,et al. Effect of oxidant exposure on thiol status in the intestinal mucosa. , 1993, Biochemical pharmacology.
[17] H. Masutani,et al. Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients. , 1992, AIDS research and human retroviruses.
[18] B. Lauterburg,et al. Glutathione depletion in HIV‐infected patients: role of cysteine deficiency and effect of oral N‐acetylcysteine , 1992, AIDS.
[19] A. Malik,et al. Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. , 1992, The Journal of clinical investigation.
[20] P. Ueland,et al. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. , 1992, Analytical biochemistry.
[21] M. Roederer,et al. N-acetylcysteine: a new approach to anti-HIV therapy. , 1992, AIDS research and human retroviruses.
[22] M. Roederer,et al. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. , 1992, AIDS research and human retroviruses.
[23] M. Schrappe,et al. T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different aetiologies. , 1992, International immunology.
[24] W. Dröge,et al. HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine. , 1992, Immunology today.
[25] M. Roederer,et al. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses , 1991 .
[26] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[27] C. Cross,et al. Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Sense or speculation? , 1991, Archives of internal medicine.
[28] M. Roederer,et al. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[29] P. Ueland,et al. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. , 1990, Analytical biochemistry.
[30] E. Smeland,et al. Functional properties of CD19 B lymphocytes positively selected from buffy coats by immunomagnetic separation , 1990, European journal of immunology.
[31] A. Holmgren,et al. Thioredoxin and glutaredoxin systems. , 2019, The Journal of biological chemistry.
[32] R. Crystal,et al. SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.
[33] N. Voelkel,et al. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. , 1989, The American journal of physiology.
[34] B. Fanburg,et al. Regulation of cellular glutathione. , 1989, The American journal of physiology.
[35] W. Dröge,et al. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. , 1989, Biological chemistry Hoppe-Seyler.
[36] R. Munday,et al. Toxicity of thiols and disulphides: involvement of free-radical species. , 1989, Free radical biology & medicine.
[37] A. Meister. Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.
[38] E. Thorsby,et al. Direct immunomagnetic quantification of lymphocyte subsets in blood. , 1988, Clinical and experimental immunology.
[39] D. Ross. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. , 1988, Pharmacology & therapeutics.
[40] W. Dröge,et al. Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. , 1988, Biological chemistry Hoppe-Seyler.
[41] W. Dröge,et al. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. , 1986, Immunobiology.
[42] H. Wedner,et al. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. , 1985, Journal of immunology.
[43] S. Orrenius,et al. Demonstration and partial characterization of glutathione disulfide-stimulated ATPase activity in the plasma membrane fraction from rat hepatocytes. , 1985, The Journal of biological chemistry.
[44] D. Ziegler. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. , 1985, Annual review of biochemistry.
[45] C. Krishnamurti,et al. Application of reversed-phase high-performance liquid chromatography using pre-column derivatization with o-phthaldialdehyde for the quantitative analysis of amino acids in adult and fetal sheep plasma, animal feeds and tissues. , 1984, Journal of chromatography.
[46] T. Waldmann,et al. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.